Pure Global

Androstenedione (Maglumi Androstenedione ) - India CDSCO Medical Device Registration

Androstenedione (Maglumi Androstenedione ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000124_aae38f4091e1cb43cd345a25305c74ee_e594e4c998d08fcac93e1e3a4ac9b814. This device is marketed under the brand name Maglumi Starter 1+2. The license holder is ANAND HEALTHCARE SERVICES, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Androstenedione (Maglumi Androstenedione )
UID: IMP/IVD/2023/000124_aae38f4091e1cb43cd345a25305c74ee_e594e4c998d08fcac93e1e3a4ac9b814

Brand Name

Maglumi Starter 1+2

Device Class

Class B

Approving Authority

CDSCO

Product Information

The kit is an in vitro chemiluminescence immunoassay for the quantitative determination of androstenedione in human serum and plasma using the MAGLUMI series Fully-auto chemiluminescence immunoassay analyzer and Biolumi series Integrated System, and the assay is used in the diagnosis and treatment of individuals with excessive levels of androgen (Maglumi Starter 1+2) production

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing